Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata is a complex condition causing hair loss, linked to genetics and immune system issues, and may be related to other autoimmune diseases; treatments vary in effectiveness.

Baricitinib effectively promotes hair regrowth in both scalp and nonscalp areas for alopecia areata universalis patients.

Baricitinib combined with other immune therapies may safely and effectively treat severe scalp hair loss.

People with alopecia areata often have lower vitamin D levels, which may be linked to the condition's severity.

DPCP is effective for treating severe alopecia areata, but relapse is common.

Hydroxychloroquine is less effective than betamethasone oral mini pulse therapy for treating alopecia areata.

Alopecia significantly lowers women's quality of life, with psychological and social challenges, highlighting the importance of early treatment and support.

Most children with alopecia areata improved with treatment, but those with more hair loss had worse outcomes.

Intralesional triamcinolone acetonide is effective for treating patchy hair loss, and dermoscopy helps detect treatment response and side effects early.

Finasteride and minoxidil are effective for hair regrowth, while treatments for alopecia areata have varying success and continuous treatment is necessary.

Persistent radiation-induced hair loss is dose-dependent, and treatments like topical minoxidil can be effective.

Platelet-rich plasma therapy is a safe and effective treatment for alopecia areata.

Advanced therapies like gene, cell, and tissue engineering show promise for hair regrowth in alopecia, but their safety and effectiveness need more verification.

Alopecia Areata is an autoimmune condition causing hair loss with no cure and treatments that often don't work well.

Alopecia areata causes hair loss, has no cure, and various treatments exist.

Alopecia areata involves specific T-cells, unlike androgenetic alopecia.

The cause of alopecia areata was unknown, and while various treatments existed, no best treatment was agreed upon.

No single treatment is consistently effective for alopecia areata, and more research is needed.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

Despite progress in treatment, the exact cause of Alopecia areata is still unknown.

Minoxidil doesn't affect perifollicular lymphoid infiltration in alopecia areata patients.

People with alopecia areata have similar retinal structures but thicker choroidal regions compared to those without the condition.

Minoxidil and finasteride are effective for male hair loss, minoxidil for female hair loss, and various treatments like corticosteroids work for alopecia areata; treatment should be tailored to the individual.

Combining microneedling with either vitamin D3 or bimatoprost improves hair regrowth more than microneedling alone.

Some vitamins and minerals like vitamin D and iron can help with certain types of hair loss, but more research is needed for others.

Contact sensitizers like DCP and SADBE are the most effective treatments for alopecia areata.

Alopecia areata may be linked to heart issues.

Children's hair loss can be caused by various factors and should be treated with appropriate, age-specific methods and psychological support.

Topical sensitizers have mixed success in treating alopecia areata.

Topical contact sensitizers can treat certain skin conditions but are rarely used in the U.K.